Loading...
THERAPEUTIC WHITE BLOOD CELL AND PLATELET DEPLETIONS USING THE SPECTRA OPTIA SYSTEM CONTINUOUS MONONUCLEAR CELL PROTOCOL
The Spectra Optia apheresis system® has only recently been approved by the Food and Drug Administration (FDA) for therapeutic white blood cell (WBC) and is not yet approved for platelet depletions. Prior to FDA-approval of the WBC depletion protocol, when our available COBE Spectra apheresis systems...
Na minha lista:
| Udgivet i: | J Clin Apher |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6852644/ https://ncbi.nlm.nih.gov/pubmed/30325054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jca.21644 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|